nodes	percent_of_prediction	percent_of_DWPC	metapath
Magnesium salicylate—PTGS2—amyotrophic lateral sclerosis	0.836	1	CbGaD
Magnesium salicylate—CNS depression NOS—Riluzole—amyotrophic lateral sclerosis	0.0139	0.0911	CcSEcCtD
Magnesium salicylate—Body temperature decreased—Riluzole—amyotrophic lateral sclerosis	0.0102	0.0667	CcSEcCtD
Magnesium salicylate—Hypothermia—Riluzole—amyotrophic lateral sclerosis	0.0102	0.0667	CcSEcCtD
Magnesium salicylate—Gastric ulcer—Riluzole—amyotrophic lateral sclerosis	0.0098	0.0643	CcSEcCtD
Magnesium salicylate—Upset stomach—Riluzole—amyotrophic lateral sclerosis	0.00869	0.057	CcSEcCtD
Magnesium salicylate—Stupor—Riluzole—amyotrophic lateral sclerosis	0.00763	0.0501	CcSEcCtD
Magnesium salicylate—Pulmonary function test decreased—Riluzole—amyotrophic lateral sclerosis	0.00756	0.0496	CcSEcCtD
Magnesium salicylate—Respiratory depression—Riluzole—amyotrophic lateral sclerosis	0.00756	0.0496	CcSEcCtD
Magnesium salicylate—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.0055	0.0361	CcSEcCtD
Magnesium salicylate—Ecchymosis—Riluzole—amyotrophic lateral sclerosis	0.00515	0.0338	CcSEcCtD
Magnesium salicylate—Deafness—Riluzole—amyotrophic lateral sclerosis	0.00462	0.0303	CcSEcCtD
Magnesium salicylate—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00357	0.0234	CcSEcCtD
Magnesium salicylate—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00343	0.0225	CcSEcCtD
Magnesium salicylate—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00325	0.0213	CcSEcCtD
Magnesium salicylate—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00305	0.02	CcSEcCtD
Magnesium salicylate—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00301	0.0197	CcSEcCtD
Magnesium salicylate—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00286	0.0188	CcSEcCtD
Magnesium salicylate—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00285	0.0187	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.0027	0.0177	CcSEcCtD
Magnesium salicylate—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00244	0.016	CcSEcCtD
Magnesium salicylate—Trisalicylate-choline—PTGS2—amyotrophic lateral sclerosis	0.00224	0.314	CrCbGaD
Magnesium salicylate—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00205	0.0134	CcSEcCtD
Magnesium salicylate—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00203	0.0133	CcSEcCtD
Magnesium salicylate—Shock—Riluzole—amyotrophic lateral sclerosis	0.002	0.0131	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00196	0.0129	CcSEcCtD
Magnesium salicylate—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00194	0.0127	CcSEcCtD
Magnesium salicylate—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.0019	0.0125	CcSEcCtD
Magnesium salicylate—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00181	0.0119	CcSEcCtD
Magnesium salicylate—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00179	0.0117	CcSEcCtD
Magnesium salicylate—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00177	0.0116	CcSEcCtD
Magnesium salicylate—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00174	0.0114	CcSEcCtD
Magnesium salicylate—Pain—Riluzole—amyotrophic lateral sclerosis	0.00174	0.0114	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00167	0.011	CcSEcCtD
Magnesium salicylate—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00161	0.0106	CcSEcCtD
Magnesium salicylate—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00144	0.00943	CcSEcCtD
Magnesium salicylate—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00139	0.00912	CcSEcCtD
Magnesium salicylate—Salicylate-sodium—PTGS2—amyotrophic lateral sclerosis	0.00136	0.19	CrCbGaD
Magnesium salicylate—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00134	0.00882	CcSEcCtD
Magnesium salicylate—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00129	0.00848	CcSEcCtD
Magnesium salicylate—Rash—Riluzole—amyotrophic lateral sclerosis	0.00128	0.00841	CcSEcCtD
Magnesium salicylate—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00128	0.0084	CcSEcCtD
Magnesium salicylate—Headache—Riluzole—amyotrophic lateral sclerosis	0.00127	0.00835	CcSEcCtD
Magnesium salicylate—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00121	0.00792	CcSEcCtD
Magnesium salicylate—Nepafenac—PTGS2—amyotrophic lateral sclerosis	0.000952	0.133	CrCbGaD
Magnesium salicylate—Olsalazine—PTGS2—amyotrophic lateral sclerosis	0.00093	0.13	CrCbGaD
Magnesium salicylate—Salsalate—PTGS2—amyotrophic lateral sclerosis	0.000791	0.111	CrCbGaD
Magnesium salicylate—Salicylic acid—PTGS2—amyotrophic lateral sclerosis	0.000486	0.0681	CrCbGaD
Magnesium salicylate—Ketoprofen—PTGS2—amyotrophic lateral sclerosis	0.000386	0.054	CrCbGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—PTPRZ1—amyotrophic lateral sclerosis	0.000163	0.0362	CbGpPWpGaD
Magnesium salicylate—PTGS2—Signaling mediated by p38-alpha and p38-beta—RAB5A—amyotrophic lateral sclerosis	0.000159	0.0354	CbGpPWpGaD
Magnesium salicylate—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—TPK1—amyotrophic lateral sclerosis	0.000157	0.035	CbGpPWpGaD
Magnesium salicylate—PTGS1—Selenium Micronutrient Network—GSR—amyotrophic lateral sclerosis	9.93e-05	0.0221	CbGpPWpGaD
Magnesium salicylate—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—amyotrophic lateral sclerosis	9.88e-05	0.022	CbGpPWpGaD
Magnesium salicylate—PTGS1—Prostaglandin Synthesis and Regulation—PLA2G4A—amyotrophic lateral sclerosis	9.53e-05	0.0212	CbGpPWpGaD
Magnesium salicylate—ALB—HDL-mediated lipid transport—APOE—amyotrophic lateral sclerosis	8.76e-05	0.0195	CbGpPWpGaD
Magnesium salicylate—PTGS2—Signaling mediated by p38-alpha and p38-beta—ATF1—amyotrophic lateral sclerosis	8.72e-05	0.0194	CbGpPWpGaD
Magnesium salicylate—PTGS2—Selenium Micronutrient Network—GSR—amyotrophic lateral sclerosis	7.88e-05	0.0175	CbGpPWpGaD
Magnesium salicylate—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—amyotrophic lateral sclerosis	7.77e-05	0.0173	CbGpPWpGaD
Magnesium salicylate—PTGS1—Overview of nanoparticle effects—PTGS2—amyotrophic lateral sclerosis	7.74e-05	0.0172	CbGpPWpGaD
Magnesium salicylate—PTGS2—Prostaglandin Synthesis and Regulation—PLA2G4A—amyotrophic lateral sclerosis	7.56e-05	0.0168	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet degranulation—TUBA4A—amyotrophic lateral sclerosis	7.15e-05	0.0159	CbGpPWpGaD
Magnesium salicylate—ALB—Response to elevated platelet cytosolic Ca2+—TUBA4A—amyotrophic lateral sclerosis	6.81e-05	0.0152	CbGpPWpGaD
Magnesium salicylate—PTGS2—Signaling mediated by p38-alpha and p38-beta—PLA2G4A—amyotrophic lateral sclerosis	6.68e-05	0.0149	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet degranulation—PFN1—amyotrophic lateral sclerosis	6.44e-05	0.0143	CbGpPWpGaD
Magnesium salicylate—PTGS1—Eicosanoid Synthesis—PTGS2—amyotrophic lateral sclerosis	6.42e-05	0.0143	CbGpPWpGaD
Magnesium salicylate—ALB—Selenium Micronutrient Network—GSR—amyotrophic lateral sclerosis	6.38e-05	0.0142	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—RTN4—amyotrophic lateral sclerosis	6.35e-05	0.0141	CbGpPWpGaD
Magnesium salicylate—PTGS1—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.33e-05	0.0141	CbGpPWpGaD
Magnesium salicylate—ALB—Response to elevated platelet cytosolic Ca2+—PFN1—amyotrophic lateral sclerosis	6.13e-05	0.0137	CbGpPWpGaD
Magnesium salicylate—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—amyotrophic lateral sclerosis	5.55e-05	0.0124	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	5.4e-05	0.012	CbGpPWpGaD
Magnesium salicylate—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—amyotrophic lateral sclerosis	5.37e-05	0.012	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—GFAP—amyotrophic lateral sclerosis	5.18e-05	0.0115	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—AQP4—amyotrophic lateral sclerosis	5.12e-05	0.0114	CbGpPWpGaD
Magnesium salicylate—ALB—Lipoprotein metabolism—APOE—amyotrophic lateral sclerosis	5.03e-05	0.0112	CbGpPWpGaD
Magnesium salicylate—PTGS2—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.02e-05	0.0112	CbGpPWpGaD
Magnesium salicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—amyotrophic lateral sclerosis	5.02e-05	0.0112	CbGpPWpGaD
Magnesium salicylate—PTGS2—S1P1 pathway—VEGFA—amyotrophic lateral sclerosis	4.84e-05	0.0108	CbGpPWpGaD
Magnesium salicylate—PTGS1—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	4.49e-05	0.00999	CbGpPWpGaD
Magnesium salicylate—ALB—Vitamin B12 Metabolism—SOD1—amyotrophic lateral sclerosis	4.46e-05	0.00993	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	4.41e-05	0.00982	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	4.41e-05	0.00981	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	4.03e-05	0.00898	CbGpPWpGaD
Magnesium salicylate—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—amyotrophic lateral sclerosis	3.92e-05	0.00873	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	3.75e-05	0.00835	CbGpPWpGaD
Magnesium salicylate—ALB—Folate Metabolism—SOD1—amyotrophic lateral sclerosis	3.63e-05	0.00808	CbGpPWpGaD
Magnesium salicylate—PTGS1—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	3.57e-05	0.00794	CbGpPWpGaD
Magnesium salicylate—PTGS2—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	3.56e-05	0.00793	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	3.53e-05	0.00785	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	3.5e-05	0.0078	CbGpPWpGaD
Magnesium salicylate—ALB—Lipid and lipoprotein metabolism—APOE—amyotrophic lateral sclerosis	3.34e-05	0.00745	CbGpPWpGaD
Magnesium salicylate—ALB—Vitamin B12 Metabolism—APOE—amyotrophic lateral sclerosis	3.29e-05	0.00733	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	3.2e-05	0.00713	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—TUBA4A—amyotrophic lateral sclerosis	3.17e-05	0.00706	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet degranulation—SOD1—amyotrophic lateral sclerosis	3.11e-05	0.00693	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	3.03e-05	0.00674	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	2.98e-05	0.00663	CbGpPWpGaD
Magnesium salicylate—ALB—Response to elevated platelet cytosolic Ca2+—SOD1—amyotrophic lateral sclerosis	2.96e-05	0.0066	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	2.94e-05	0.00654	CbGpPWpGaD
Magnesium salicylate—ALB—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	2.88e-05	0.00642	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—PFN1—amyotrophic lateral sclerosis	2.86e-05	0.00636	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	2.83e-05	0.00631	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	2.8e-05	0.00623	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	2.77e-05	0.00616	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—BDNF—amyotrophic lateral sclerosis	2.65e-05	0.0059	CbGpPWpGaD
Magnesium salicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—amyotrophic lateral sclerosis	2.63e-05	0.00585	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	2.59e-05	0.00577	CbGpPWpGaD
Magnesium salicylate—ALB—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	2.59e-05	0.00576	CbGpPWpGaD
Magnesium salicylate—PTGS1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.56e-05	0.00571	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	2.42e-05	0.00538	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	2.41e-05	0.00536	CbGpPWpGaD
Magnesium salicylate—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	2.39e-05	0.00531	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	2.36e-05	0.00525	CbGpPWpGaD
Magnesium salicylate—PTGS1—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	2.27e-05	0.00505	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	2.26e-05	0.00504	CbGpPWpGaD
Magnesium salicylate—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—amyotrophic lateral sclerosis	2.24e-05	0.00499	CbGpPWpGaD
Magnesium salicylate—ALB—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	2.2e-05	0.0049	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	2.14e-05	0.00476	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	2.04e-05	0.00454	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—VAPB—amyotrophic lateral sclerosis	1.96e-05	0.00437	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—TPK1—amyotrophic lateral sclerosis	1.96e-05	0.00437	CbGpPWpGaD
Magnesium salicylate—ALB—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	1.96e-05	0.00437	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	1.92e-05	0.00427	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet degranulation—IGF1—amyotrophic lateral sclerosis	1.9e-05	0.00422	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—TPK1—amyotrophic lateral sclerosis	1.86e-05	0.00415	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.83e-05	0.00408	CbGpPWpGaD
Magnesium salicylate—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—amyotrophic lateral sclerosis	1.81e-05	0.00402	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	1.8e-05	0.00401	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—VAPA—amyotrophic lateral sclerosis	1.8e-05	0.004	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	1.72e-05	0.00383	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.67e-05	0.00372	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	1.63e-05	0.00364	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—FIG4—amyotrophic lateral sclerosis	1.57e-05	0.0035	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—TPK1—amyotrophic lateral sclerosis	1.56e-05	0.00347	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—VAPB—amyotrophic lateral sclerosis	1.56e-05	0.00347	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	1.55e-05	0.00346	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—RAB5A—amyotrophic lateral sclerosis	1.52e-05	0.00338	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—VTA1—amyotrophic lateral sclerosis	1.49e-05	0.00331	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—PFN1—amyotrophic lateral sclerosis	1.47e-05	0.00328	CbGpPWpGaD
Magnesium salicylate—ALB—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	1.46e-05	0.00325	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.45e-05	0.00324	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—VAPA—amyotrophic lateral sclerosis	1.43e-05	0.00318	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—DAO—amyotrophic lateral sclerosis	1.42e-05	0.00316	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	1.38e-05	0.00307	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.33e-05	0.00295	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—CASP3—amyotrophic lateral sclerosis	1.32e-05	0.00295	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	1.32e-05	0.00293	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—TPK1—amyotrophic lateral sclerosis	1.26e-05	0.00281	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—VAPB—amyotrophic lateral sclerosis	1.26e-05	0.00281	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—MMP9—amyotrophic lateral sclerosis	1.25e-05	0.00278	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—FIG4—amyotrophic lateral sclerosis	1.25e-05	0.00278	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet degranulation—VEGFA—amyotrophic lateral sclerosis	1.24e-05	0.00276	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	1.24e-05	0.00276	CbGpPWpGaD
Magnesium salicylate—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—amyotrophic lateral sclerosis	1.18e-05	0.00263	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.18e-05	0.00262	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	1.17e-05	0.0026	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—VAPA—amyotrophic lateral sclerosis	1.15e-05	0.00257	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CHMP2B—amyotrophic lateral sclerosis	1.13e-05	0.00251	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—DAO—amyotrophic lateral sclerosis	1.13e-05	0.00251	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	1.12e-05	0.00249	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	1.12e-05	0.00249	CbGpPWpGaD
Magnesium salicylate—ALB—Folate Metabolism—TP53—amyotrophic lateral sclerosis	1.09e-05	0.00243	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.08e-05	0.0024	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.07e-05	0.00239	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PLB1—amyotrophic lateral sclerosis	1.02e-05	0.00227	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—FIG4—amyotrophic lateral sclerosis	1.01e-05	0.00225	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	9.97e-06	0.00222	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—GSR—amyotrophic lateral sclerosis	9.93e-06	0.00221	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—DAO—amyotrophic lateral sclerosis	9.12e-06	0.00203	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—VCP—amyotrophic lateral sclerosis	9.09e-06	0.00202	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	9.05e-06	0.00201	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	9e-06	0.002	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PLB1—amyotrophic lateral sclerosis	8.54e-06	0.0019	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—TP53—amyotrophic lateral sclerosis	8.48e-06	0.00189	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	8.42e-06	0.00187	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CHAT—amyotrophic lateral sclerosis	8.16e-06	0.00182	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—GSR—amyotrophic lateral sclerosis	7.89e-06	0.00176	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	7.64e-06	0.0017	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	7.44e-06	0.00166	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	7.18e-06	0.0016	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—SOD1—amyotrophic lateral sclerosis	7.12e-06	0.00158	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PLB1—amyotrophic lateral sclerosis	6.91e-06	0.00154	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CST3—amyotrophic lateral sclerosis	6.53e-06	0.00145	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CHAT—amyotrophic lateral sclerosis	6.48e-06	0.00144	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	6.38e-06	0.00142	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GSR—amyotrophic lateral sclerosis	6.38e-06	0.00142	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	5.91e-06	0.00132	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	5.81e-06	0.00129	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	5.77e-06	0.00128	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	5.5e-06	0.00122	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CHAT—amyotrophic lateral sclerosis	5.24e-06	0.00117	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	5.1e-06	0.00114	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	4.78e-06	0.00106	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CASP9—amyotrophic lateral sclerosis	4.75e-06	0.00106	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.38e-06	0.000976	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—IGF1—amyotrophic lateral sclerosis	4.34e-06	0.000966	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—ERBB4—amyotrophic lateral sclerosis	4.06e-06	0.000904	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.03e-06	0.000897	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.48e-06	0.000775	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—APOE—amyotrophic lateral sclerosis	3.31e-06	0.000738	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	3.28e-06	0.000729	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.2e-06	0.000712	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—APOE—amyotrophic lateral sclerosis	3.14e-06	0.000699	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—VEGFA—amyotrophic lateral sclerosis	2.83e-06	0.000631	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.82e-06	0.000627	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—APOE—amyotrophic lateral sclerosis	2.63e-06	0.000586	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.59e-06	0.000576	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.27e-06	0.000506	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—TP53—amyotrophic lateral sclerosis	2.14e-06	0.000477	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—APOE—amyotrophic lateral sclerosis	2.13e-06	0.000474	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.46e-06	0.000325	CbGpPWpGaD
